Course Information

Release date: October 31, 2025

Expiration date: October 31, 2026

Estimated time to complete activity: 15 minutes

PROVIDER STATEMENT

This activity is provided by Integrity CE, LLC.

DISCLOSURE OF COMMERCIAL SUPPORT

This educational activity is supported by an independent medical education grant from GSK.

PROGRAM OVERVIEW

Respiratory syncytial virus (RSV) is a seasonal infection that can lead to serious illness in infants, older adults, immunocompromised individuals, and those with chronic conditions such as chronic obstructive pulmonary disease (COPD), asthma, heart disease, diabetes, or kidney disease. Adults ≥65 years of age account for an estimated 60,000–160,000 hospitalizations and 6,000–10,000 deaths annually. In response, the Advisory Committee on Immunization Practices (ACIP) updated its guidance in 2024 to recommend RSV vaccination for all adults ≥75 years of age and those aged 60–74 years with risk factors for severe disease. More recently, in April 2025, ACIP expanded eligibility to people aged 50–59 years who are at high risk for severe RSV. This activity will examine disease burden along with the factors that increase the risk for severe RSV disease in older adults.

Learning Objective

TARGET AUDIENCE

This activity addresses the needs of family physicians and other clinicians involved in the management of patients at risk for RSV.

LEARNING OBJECTIVE

Upon completion of this educational activity, participants should be able to:

Discuss the burden of RSV infection in adults, identifying factors that increase the risk for severe RSV disease

Faculty Information and Disclosures

FACULTY CHAIR

Ann R. Falsey, MD

Professor of Medicine, Infectious Diseases

Department of Medicine & Infectious Diseases

University of Rochester School of Medicine and Dentistry

Codirector, NIAID Vaccine Treatment and Evaluation Unit

Rochester, New York

FACULTY PRESENTERS

Stefan Gravenstein, MD, MPH

Professor of Medicine and Public Health
Director, Division of Geriatrics and Palliative Medicine
Warren Alpert Medical School of Brown University
Providence, Rhode Island    

Edward E. Walsh, MD
Professor of Medicine
University of Rochester School of Medicine and Dentistry
Infectious Disease Division
Rochester, New York

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity CE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity CE, LLC for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Ann R. Falsey, MD

Advisory Board Honoraria: ADMA Biologics, GSK, Merck, Moderna, Sanofi

Research Funding: AstraZeneca, CyanVac, Moderna, Pfizer, Sanofi

Stefan Gravenstein, MD, MPH

Advisory Board Honoraria & Consulting: AstraZeneca/Icosavax, CureVac, Genentech, GSK, Janssen/Johnson & Johnson, Moderna, Novavax, Pfizer, Sanofi, Seqirus, Shionogi

Grant Support: Genentech, GSK, Janssen/Johnson & Johnson, Moderna, Pfizer, Seqirus

Edward E. Walsh, MD

Consultant: GSK, Merck, Moderna, Pfizer

Grant Support: Merck, Moderna, Pfizer

Speaker: Sanofi

The Integrity CE, LLC planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

Accreditation Information

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of October 31, 2025 through October 31, 2026, participants must:

Read the learning objectives
Complete the pretest
Study the educational activity
Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed posttest with a score of 50% or better and a completed activity evaluation form. A statement of credit will be issued by our system and immediately available to download following your completion of the posttest and evaluation.

ACCREDITATION STATEMENT

Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity CE, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers and Technical Requirements

MEDIA

Internet

PRIVACY POLICY

When you register or participate in an educational activity sponsored by Integrity CE, LLC, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Internet: Stable connection
Operating Systems: Windows 10/macOS 10.14 or later recommended
Web Browser: Latest versions of Google Chrome, Microsoft Edge, or Safari recommended (other modern browsers also supported)
Plug-ins: No plug-ins required

For optimal performance and security, ensure your browser is up to date and avoid using unsupported or outdated versions

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

RSV Burden: Risk Factors, Incidence, Hospitalization, Mortality